Recent Price Movement and Market Context
The stock has been on a downward trend for the past three consecutive trading sessions, losing a cumulative -6.18% over this period. Today’s fall of -0.43% further extended its underperformance relative to the Specialty Chemicals sector, where it lagged by -0.75%. Jaysynth Orgochem is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum.
In contrast, the broader market has shown resilience with the Sensex opening higher at 82,459.66 points, gaining 550.03 points (0.67%) before settling near 82,270.40 points, a 0.44% rise. Despite this, the Sensex remains on a three-week losing streak, down -4.07%, and is currently 4.73% below its 52-week high of 86,159.02. Mid-cap stocks have led gains recently, with the BSE Mid Cap index rising 1.21% today, highlighting a divergence in market segments.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Performance Overview and Valuation Metrics
Over the past year, Jaysynth Orgochem Ltd has experienced a steep decline of -49.03%, a stark contrast to the Sensex’s positive return of 7.68% and the BSE500’s 7.19% gain. The stock’s 52-week high was Rs.29.2, indicating a near 54% drop from that peak. This underperformance is reflected in its current Mojo Score of 37.0 and a Mojo Grade of Sell, downgraded from Hold as of 5 August 2025.
Despite the price decline, the company’s valuation metrics present a mixed picture. The Return on Capital Employed (ROCE) stands at a moderate 13.6%, and the Enterprise Value to Capital Employed ratio is 1.5, suggesting the stock is trading at a fair value relative to its peers’ historical averages. Additionally, the company’s PEG ratio is 0.2, indicating that profits have grown faster than the stock price has appreciated, with profits rising by 78.9% over the last year.
Financial and Operational Highlights
Jaysynth Orgochem’s financial performance reveals some areas of concern alongside strengths. The company’s Return on Equity (ROE) remains low at 4.22%, signalling limited profitability generated from shareholders’ funds. Operating cash flow for the year was recorded at Rs.6.33 crores, the lowest in recent periods, reflecting constrained liquidity generation.
On the positive side, the company has demonstrated strong long-term growth, with net sales increasing at an annual rate of 180.70% and operating profit growing by 79.87%. The firm maintains a healthy debt profile, with a low Debt to EBITDA ratio of 0.67 times, indicating a strong ability to service its debt obligations without undue financial strain.
Shareholding and Sector Positioning
The majority shareholding remains with the promoters, providing a stable ownership structure. Operating within the Specialty Chemicals sector, Jaysynth Orgochem faces competitive pressures and sector-specific dynamics that influence its market valuation and performance. The sector itself has seen varied performances, with some mid-cap companies outperforming broader indices, while others, including Jaysynth Orgochem, have struggled to maintain momentum.
Why settle for Jaysynth Orgochem Ltd? SwitchER evaluates this Specialty Chemicals micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Summary of Key Metrics
To summarise, Jaysynth Orgochem Ltd’s current stock price of Rs.13.5 represents a significant low point within the last 52 weeks, reflecting a combination of subdued profitability, recent price weakness, and sector headwinds. The company’s financial indicators show a blend of low ROE and operating cash flow alongside robust sales and profit growth and a manageable debt load. The stock’s downgrade to a Sell grade by MarketsMOJO on 5 August 2025 underscores the cautious stance on its near-term outlook.
While the broader market and mid-cap segments have shown pockets of strength, Jaysynth Orgochem’s performance remains subdued, with the stock trading well below all major moving averages and continuing its downward trend over recent sessions. Investors and analysts will likely continue to monitor the company’s financial results and sector developments closely as the year progresses.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
